Neurobiomat
Developing hydrogel-based spinal cord repair treatments for people with chronic spinal cord injuries
Highlights
- New on EvolcAdded 2026-11-13
About Neurobiomat
NeuroBioMat develops hydrogel-based technology intended to repair injured spinal cords in the chronic stage. Its SPINEREP medical device uses a macromolecular scaffold at the injury site to support nerve-fiber regeneration.
The company aims to develop treatments for patients with severe motor and sensory disabilities. It was founded in 2018 and is based in Archamps, France; it describes itself as a French start-up and says it is supported by Bpifrance.
Product: SPINEREP, a medical device using hydrogel-based scaffolding technology for spinal cord repair.
Jobs at Neurobiomat
Leadership
- Stéphane Woerly · President, Chief Scientific Officer Chief Medical OfficerSource: company website
More biotech & pharma companies
Neurofit
Preclinical neuroscience research models and testing services for biopharmaceutical drug developersNeuron Experts
Preclinical cell-model research and advisory for pharmaceutical, biotechnology and cosmetics companies developing neuro-active compoundsNevezyne
Custom recombinant therapeutic protein expression and purification services for biotechnology and pharmaceutical researchersYoung companyNew on EvolcNexidia
Applied microbiology services for organizations developing probiotics and ferments or managing harmful microorganismsNew on EvolcNextpharma
Contract development and manufacturing of pharmaceuticals across ten European sites for pharma and nutrition brand ownersNFL Biosciences
Develops botanical drug candidates for smoking cessation and excessive alcohol consumptionNew on Evolc
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Content delivery
- CloudflareHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Response headerserver
- Response headerserver
- Response headerserver
Content management
- WixHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Frontend frameworks
- ReactMedium confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Page markupsoftware structure signature
- Page markupsoftware structure signature
- Page markupsoftware structure signature
Monitoring
- SentryHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.
